Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.

After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest version of its transcatheter aortic valve replacement implant.

Conemaugh Memorial Medical Center celebrates 500th transcatheter aortic valve replacement procedure Pictured from left are ...

Aortic regurgitation occurs when blood leaks back into the left ventricle due to a leaky aortic valve. This is a type of valve disease in the heart. Aortic regurgitation can lead to some heart ...

This is because space is required to accommodate the excluded native aortic valve leaflets, which otherwise could compromise coronary arterial flow. Since the Medtronic CoreValve device is a much ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

(Heart) For patients with systolic heart failure and moderate aortic stenosis, preemptive transcatheter aortic valve replacement ... (JAMA Cardiology) Medtronic announced FDA approval of its ...

The Evolut FX+ transcatheter aortic valve replacement (TAVR) system. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Evolut FX+ ...